The New Yorker Radio Hour cover image

Jia Tolentino on the Ozempic Weight-Loss Craze

The New Yorker Radio Hour

00:00

Introduction

Ozempic was first approved in 2017 as a treatment for type 2 diabetes. Staff writer, Geotone Tino, has been reporting on the use and misuse of Ozempic. And what it says about our relationships to our bodies today.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app